logo
Select company
Select metric
$ -8.99MCapital Expenditure
VS
Market
98
Sector
100
Industry
100
History
98
$ 3.04Close
$ 1.41 - $ 15.24 52-Week Range
Ticker Information

Ticker

VIVS

Company Name

VIVOSIM LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIVOSIM LABS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIVS - CapEx Historical data
DateCapital Expenditure
6/30/2025$ -8.99M
3/31/2025$ -8.99M
12/31/2024$ 13K
9/30/2024$ 13K
6/30/2024$ 27K
3/31/2024$ 42K
12/31/2023$ 204K
9/30/2023$ 245K
6/30/2023$ 337K
3/31/2023$ 396K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOSIM LABS INC's latest trailing twelve months (TTM) CapEx stands at $ -727K.
  • Over the past 5 years, VIVOSIM LABS INC's average CapEx has been $ -686.25K.
  • The median CapEx for VIVOSIM LABS INC during this period was $ 275K
  • VIVOSIM LABS INC reached its highest CapEx over the past 5 years at $ 623K.
  • The lowest CapEx recorded by VIVOSIM LABS INC in the same timeframe $ -8.99M

VIVOSIM LABS INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
AIM : AIM IMMUNOTECH INC $ 301KSILO : SILO PHARMA INC $ 0GLTO : GALECTO INC $ 0DRMA : DERMATA THERAPEUTICS INC $ 0ADTX : ADITXT INC $ 0OGEN : ORAGENICS INC $ 0HCWB : HCW BIOLOGICS INC $ 150.47KSLRX : SALARIUS PHARMACEUTICALS INC $ 0TOVX : THERIVA BIOLOGICS INC $ 16KREVB : REVELATION BIOSCIENCES INC $ -1

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

VIVS - Capital Expenditure, Last 5 years

$ -8.99M

Minimum

Mar 31, 2025

$ 623K

Maximum

Sep 30, 2021

$ -686.25K

Average

$ 275K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.73M with a standard deviation of $ 15.95M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.95M
average$ 9.73M
median$ 1.95M
std$ 15.95M